106 related articles for article (PubMed ID: 15478015)
1. Head and Neck Cancer--Sixth International Conference. 7-11 August 2004, Washington, DC, USA.
Susman E
IDrugs; 2004 Oct; 7(10):917-9. PubMed ID: 15478015
[No Abstract] [Full Text] [Related]
2. American Association for Cancer Research--94th Annual Meeting. New compounds. 11-14 July 2003, Washington, DC, USA.
Mackay J; Williams L
IDrugs; 2003 Aug; 6(8):733-5. PubMed ID: 12971387
[No Abstract] [Full Text] [Related]
3. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
4. [Paclitaxel (Taxol) in chemotherapy of head and neck cancer--just another proposal or breakthrough?].
Górecka KM; Golusiński W; Gawecki W; Szyfter K
Otolaryngol Pol; 2001; 55(5):471-6. PubMed ID: 11868318
[TBL] [Abstract][Full Text] [Related]
5. Hypothermia with epodyl in the treatment of cancer of the head and neck.
Harrison DF
Geriatrics; 1969 Jul; 24(7):87-97. PubMed ID: 5789862
[No Abstract] [Full Text] [Related]
6. Radiosensitization in head and neck cancer: do we have an alternative to platins? Role of taxanes.
Joseph B; Vishwanath L; Venugopal BK
Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Mar; 117(3):324-8. PubMed ID: 24388535
[TBL] [Abstract][Full Text] [Related]
7. Antitumor effects of epidermal growth factor receptor antisense oligonucleotides in combination with docetaxel in squamous cell carcinoma of the head and neck.
Niwa H; Wentzel AL; Li M; Gooding WE; Lui VW; Grandis JR
Clin Cancer Res; 2003 Oct; 9(13):5028-35. PubMed ID: 14581378
[TBL] [Abstract][Full Text] [Related]
8. The Fox Chase Cancer Center and Free University Hospital Investigators' Workshop and Consensus Conference on Paclitaxel. Part 3: Gynecologic malignancies, head and neck cancer, and other tumor types. Marrakech, Morocco, January 18-20, 1996 and St Croix, Virgin Islands, March 13-16, 1996.
Semin Oncol; 1997 Feb; 24(1 Suppl 2):S2-1-S2-120; quiz S2-121-S2-123. PubMed ID: 9045323
[No Abstract] [Full Text] [Related]
9. Docetaxel said to be highly effective and well tolerated in advanced head and neck cancer.
Oncology (Williston Park); 1996 Mar; 10(3):422. PubMed ID: 8820455
[No Abstract] [Full Text] [Related]
10. Serum vascular endothelial growth factor as a predictive factor in metronomic (weekly) Paclitaxel treatment for advanced head and neck cancer.
Caballero M; Grau JJ; Blanch JL; Domingo-Domenech J; Auge JM; Jimenez W; Bernal-Sprekelsen M
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1143-8. PubMed ID: 18025320
[TBL] [Abstract][Full Text] [Related]
11. Head and neck cancer.
Taylor SG
Cancer Chemother Biol Response Modif; 1988; 10():210-21. PubMed ID: 3079384
[No Abstract] [Full Text] [Related]
12. [Therapeutic effect of adenovirus-mediated transfer of the wild-type p53 gene with cisplatin].
Fujiwara T; Ogawa N; Kagawa S; Nishizaki M; Yasuda T; Tanaka N; Orita K; Roth JA
Gan To Kagaku Ryoho; 1996 Jul; 23(8):1085-8. PubMed ID: 8687228
[No Abstract] [Full Text] [Related]
13. Oncolytic viruses: a new paradigm for treatment of head and neck cancer.
Lott JB
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):155-60. PubMed ID: 22677730
[No Abstract] [Full Text] [Related]
14. Head and neck cancer.
Taylor SG
Cancer Chemother Biol Response Modif; 1991; 12():431-42. PubMed ID: 1931453
[No Abstract] [Full Text] [Related]
15. [Decision making in non resectable head and neck tumours].
Dietz A; Weber A; Dollner R; Hildebrandt G
Laryngorhinootologie; 2005 Mar; 84(3):200-6; quiz 207-10. PubMed ID: 15770570
[TBL] [Abstract][Full Text] [Related]
16. Interactions between ionizing radiation and drugs in head and neck cancer: how can we maximize the therapeutic index?
Harrington KJ; Nutting CM
Curr Opin Investig Drugs; 2002 May; 3(5):807-11. PubMed ID: 12090557
[No Abstract] [Full Text] [Related]
17. [Docetaxel: a new weapon in the treatment of head and neck tumors].
Melano M
Tumori; 2001; 87(6):A9-10. PubMed ID: 11995709
[No Abstract] [Full Text] [Related]
18. Combined modality therapy of head and neck cancer.
Stupp R; Weichselbaum RR; Vokes EE
Semin Oncol; 1994 Jun; 21(3):349-58. PubMed ID: 8209266
[No Abstract] [Full Text] [Related]
19. Chemotherapy in Children with Head and Neck Cancers: Perspectives and Review of Current Therapies.
Choi DK; Schmidt ML
Oral Maxillofac Surg Clin North Am; 2016 Feb; 28(1):127-38. PubMed ID: 26614705
[TBL] [Abstract][Full Text] [Related]
20. Targeted therapies in squamous cell carcinoma of the head and neck.
Gold KA; Lee HY; Kim ES
Cancer; 2009 Mar; 115(5):922-35. PubMed ID: 19156911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
